Technicals for Eris Lifesciences Limited

Price Summary

Eris Lifesciences Limited's stock opened at 1369.9 on 2026-06-03, surged to 1412.0, dropped to 1360.0, and ended 1.99% higher at 1397.1, with 112687 shares traded.
The top price for the stock in the last 52 weeks is 1847.7, with the bottom price being 1271.0.

Technicals

Support and Resistance: The price of 1397.1 is supported at 1385.6 and faces resistance at 1441.2. This range suggests key levels for ERIS where the price may stabilize, with 1385.6 acting as a support and 1441.2 as a cap on gains.


Aroon: The AROON is showing a neutral stance, not indicating a clear upward or downward trend for Eris Lifesciences Limited. This suggests a period of market balance, where neither side is showing dominance.


Bol. Bands: The BOLL BANDS is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.


Parabolic SAR: The PSAR continues its bearish trend, setting a resistance level that could prevent significant upward movement for ERIS. This resistance suggests that the market may struggle to overcome bearish forces, keeping upward momentum in check.


Stochastic: The STOCHASTIC is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.


Before focusing on a company's technical data, such as stock price movements, it's essential to analyze its fundamentals. These include factors like profitability, cash flow, and debt management. Additionally, considering the broader industry landscape—including market trends, competition, and regulatory changes—offers deeper insights. This comprehensive approach allows for a more meaningful interpretation of the company's technical indicators, providing a clearer picture of its financial health and future prospects.